On August 22, 2023 our very own Dr Willie McKinney, CEO, had the opportunity to express his views and opinions […] Read More
3 min. read
Resources
14 min. read
Hey Doc: Do You Really Want to Stop Your Patients From Smoking?
For patients who can’t quit smoking there are several reduced-harm alternatives. None of these alternative nicotine products are safe. They […] Read More
4 min. read
Unlock the Benefits of ITP: A Comprehensive Guide to Investigational Tobacco Product Applications
It’s no secret that the FDA’s requirements for investigational tobacco product (ITP) applications can be confusing. But what if you […] Read More
6 min. read
How to communicate tobacco products’ relative risks more effectively
By Cheryl K. Olson As part of its new strategic plan, the U.S. Food and Drug Administration’s Center for Tobacco Products […] Read More
6 min. read
Correcting The Record
by Cheryl K. Olson, M.P.H., Sc.D, originally featured in the Tobacco Reporter On August 22, the U.S. Food and Drug Administration’s […] Read More
2 min. read
McKinney Regulatory Science Advisors Launches Innovative New Website
McKinney Regulatory Science Advisors (RSA) is proud to announce the launch of its new website, ushering in a new era […] Read More
6 min. read
Why Investigate the Motivations Behind Consumer Product Use?
The primary motivation for the use of medicines is to rectify physiological or psychological perturbations, although the non-therapeutic abuse of […] Read More
3 min. read
McKinney RSA Welcomes Ian Fearon as Chief Scientific Officer
McKinney Regulatory Science Advisors, LLC, a leading regulatory science consulting firm specializing in regulatory affairs, is thrilled to announce the […] Read More
8 min. read
Fighting the Dip Mentality
What will it take for women who smoke to consider smokeless? by Cheryl K. Olson, M.P.H., Sc.D, originally featured in […] Read More
Contact Us
"*" indicates required fields